Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Domatinostat plus Avelumab in GI Cancers (EMERGE)
NCT03812796Phase 2Unknown
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Jan 2019
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
A Phase 2 trial of Domatinostat in colorectal cancer (CRC), gastroesophageal junction cancer, sponsored by Royal Marsden NHS Foundation Trust. Status: unknown.
02
Drugs
Domatinostat
03
Conditions
colorectal cancer (CRC)gastroesophageal junction cancer
Beyond the preview
Go deeper on NCT03812796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03812796.